Literature DB >> 3806619

Activation mechanisms of mafosfamide and the role of thiols in cyclophosphamide metabolism.

C H Kwon, R F Borch, J Engel, U Niemeyer.   

Abstract

cis-Mafosfamide (cis-5) (ASTA Z7557), a stable analogue of cis-4-hydroxycyclophosphamide (cis-2), undergoes rapid decomposition in aqueous phosphate buffer or plasma at pH 7.4 and 37 degrees C. The reaction kinetics of cis-5 are complex, and trans-mafosfamide (trans-5) and cis-2 are produced and subsequently disappear over the course of the reaction. The rates of decomposition of cis-5 as well as cis-2 were much faster in plasma than in buffer. The cis-trans isomerization of cis-5 occurred by a specific-base-catalyzed process via iminocyclophosphamide (8) as a transient intermediate. In contrast, formation of cis- and trans-mafosfamide (5) from cis-2 and MESNA (sodium 2-mercaptoethanesulfonate) proceeded by an acid-catalyzed process via the hemithioacetal intermediate (6). The significance of these findings with respect to cyclophosphamide metabolism is discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3806619     DOI: 10.1021/jm00385a023

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer.

Authors:  Peter A Fasching; Duan Liu; Steve Scully; Lothar Häberle; Richard M Weinshilboum; Liewei Wang; James N Ingle; Paulo C Lyra; Brigitte Rack; Alexander Hein; Arif B Ekici; Andre Reis; Andreas Schneeweiss; Hans Tesch; Tanja N Fehm; Georg Heinrich; Matthias W Beckmann; Matthias Ruebner; Hanna Huebner; Diether Lambrechts; Ebony Madden; Jess Shen; Jane Romm; Kim Doheny; Gregory D Jenkins; Erin E Carlson; Liang Li; Brooke L Fridley; Julie M Cunningham; Wolfgang Janni; Alvaro N A Monteiro; Daniel J Schaid
Journal:  Clin Cancer Res       Date:  2022-08-02       Impact factor: 13.801

2.  Chemotherapy induces tumor clearance independent of apoptosis.

Authors:  Jennifer L Guerriero; Dara Ditsworth; Yongjun Fan; Fangping Zhao; Howard C Crawford; Wei-Xing Zong
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

3.  Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamide.

Authors:  T H Inge; S K Hoover; J L Frank; T T Kawabata; K P Bethke; H D Bear
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

4.  Glutathione diminishes the anti-tumour activity of 4-hydroperoxycyclophosphamide by stabilising its spontaneous breakdown to alkylating metabolites.

Authors:  F Y Lee
Journal:  Br J Cancer       Date:  1991-01       Impact factor: 7.640

5.  Prediction of tumour sensitivity to 4-hydroperoxycyclophosphamide by a glutathione-targeted assay.

Authors:  F Y Lee; D J Flannery; D W Siemann
Journal:  Br J Cancer       Date:  1991-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.